Financing type:  underwritten prospectus offering

Gross proceeds:  $11.5-million (with overallotment)

Offering:  10 million listed shares (11.5 million listed shares with overallotment)

Offering price:  $1 per listed share

Overallotment option:  The underwriters may purchase a maximum of 1.5 million listed shares for overallotment purposes. As of Sept. 4, 2024, such option was exercised in full and 1.5 million listed shares have been issued thereunder. All information presented herein includes such exercise.

Disclosure:  Refer to the base shelf prospectus dated April 25, 2023, the prospectus supplement dated Aug. 22, 2024, and the company's new release dated Sept. 4, 2024.